News
As previously reported, Wedbush initiated coverage of Wave Life Sciences (WVE) with an Outperform rating and $18 price target Wave stands out ...
Wedbush initiated coverage of Wave Life Sciences (WVE) with an Outperform rating and $18 price target Stay Ahead of the Market: Discover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results